Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity
Authors
Keywords
-
Journal
Journal of Extracellular Vesicles
Volume 8, Issue 1, Pages 1670893
Publisher
Informa UK Limited
Online
2019-09-29
DOI
10.1080/20013078.2019.1670893
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fragmented hyaluronan has no alarmin function assessed in arthritis synovial fibroblast and chondrocyte cultures
- (2018) Mia Olsson et al. Innate Immunity
- IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor
- (2018) Keishi Adachi et al. NATURE BIOTECHNOLOGY
- The Role of Toll-Like Receptor in Inflammation and Tumor Immunity
- (2018) Xiaohong Cen et al. Frontiers in Pharmacology
- Engineering Exosomes for Cancer Therapy
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exosomes in Cancer Nanomedicine and Immunotherapy: Prospects and Challenges
- (2017) Nicholas L. Syn et al. TRENDS IN BIOTECHNOLOGY
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Dual Faces of IFN in Cancer Progression: A Role of PD-L1 Induction in the Determination of Pro- and Antitumor Immunity
- (2016) M. Mandai et al. CLINICAL CANCER RESEARCH
- Hyaluronic acid in digestive cancers
- (2016) Ruo-Lin Wu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery
- (2016) Dominique Ingato et al. JOURNAL OF CONTROLLED RELEASE
- Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
- (2016) Kelly D Moynihan et al. NATURE MEDICINE
- Learning from PD-1 Resistance: New Combination Strategies
- (2016) Xia Bu et al. TRENDS IN MOLECULAR MEDICINE
- Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-α, interleukin-12 or upregulate co-stimulatory molecules in dendritic cells or macrophages
- (2016) Yifei Dong et al. Scientific Reports
- Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases
- (2015) Thanh-Huyen Tran et al. CLINICAL IMMUNOLOGY
- High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation
- (2015) Jamie E. Rayahin et al. ACS Biomaterials-Science & Engineering
- Lipid Raft-Mediated Regulation of Hyaluronan–CD44 Interactions in Inflammation and Cancer
- (2015) Toshiyuki Murai Frontiers in Immunology
- Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer
- (2015) Suniti Misra et al. Frontiers in Immunology
- High and Low Molecular Weight Hyaluronic Acid Differentially Influence Macrophage Activation
- (2015) Jamie E. Rayahin et al. ACS Biomaterials Science & Engineering
- Hyaluronan digestion controls DC migration from the skin
- (2014) Jun Muto et al. JOURNAL OF CLINICAL INVESTIGATION
- Many faces of DAMPs in cancer therapy
- (2013) O Krysko et al. Cell Death & Disease
- Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44
- (2013) K Fuchs et al. Cell Death & Disease
- Costimulatory Molecules on Immunogenic Versus Tolerogenic Human Dendritic Cells
- (2013) Mario Hubo et al. Frontiers in Immunology
- Enzymatic Targeting of the Stroma Ablates Physical Barriers to Treatment of Pancreatic Ductal Adenocarcinoma
- (2012) Paolo P. Provenzano et al. CANCER CELL
- Therapeutic Targeting of Hyaluronan in the Tumor Stroma
- (2012) Anne Kultti et al. Cancers
- Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma
- (2011) Laura Alaniz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- DAMPening Inflammation by Modulating TLR Signalling
- (2010) A. M. Piccinini et al. MEDIATORS OF INFLAMMATION
- Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
- (2010) Laura Alaniz et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Enzymatic Depletion of Tumor Hyaluronan Induces Antitumor Responses in Preclinical Animal Models
- (2010) C. B. Thompson et al. MOLECULAR CANCER THERAPEUTICS
- Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
- (2009) B. P. Toole CLINICAL CANCER RESEARCH
- CD44 Costimulation Promotes FoxP3+ Regulatory T Cell Persistence and Function via Production of IL-2, IL-10, and TGF-
- (2009) P. L. Bollyky et al. JOURNAL OF IMMUNOLOGY
- Blocking TLR2 Activity Attenuates Pulmonary Metastases of Tumor
- (2009) Hong-Zhen Yang et al. PLoS One
- Impact of the hyaluronan-rich tumor microenvironment on cancer initiation and progression
- (2008) Naoki Itano et al. CANCER SCIENCE
- LPS/TLR4 signal transduction pathway
- (2008) Yong-Chen Lu et al. CYTOKINE
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search